Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

The Prostate
S R DenmeadeJ T Isaacs

Abstract

Cells possess within their epigenetic repertoire the ability to undergo an active process of cellular suicide termed programmed (or apoptotic) cell death. This programmed cell death process involves an epigenetic reprogramming of the cell that results in an energy-dependent cascade of biochemical and morphologic changes (also termed apoptosis) within the cell, resulting in its death and elimination. Although the final steps (i.e., DNA and cellular fragmentation) are common to cells undergoing programmed cell death, the activation of this death process is initiated either by sufficient injury to the cell induced by various exogenous damaging agents (e.g., radiation, chemicals, viruses) or by changes in the levels of a series of endogenous signals (e.g., hormones and growth/survival factors). Within the prostate, androgens are capable of both stimulating proliferation as well as inhibiting the rate of the glandular epithelial cell death. Androgen withdrawal triggers the programmed cell death pathway in both normal prostate glandular epithelia and androgen-dependent prostate cancer cells. Androgen-independent prostate cancer cells do not initiate the programmed cell death pathway upon androgen ablation; however, they do retain the...Continue Reading

References

Nov 1, 1992·The Journal of Cell Biology·Y GavrieliS A Ben-Sasson
Aug 1, 1991·Experimental Cell Research·B BrüneS Orrenius
Jan 3, 1990·Journal of the National Cancer Institute·J Folkman
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·O ThastrupA P Dawson
Jan 1, 1990·The Prostate·P Martikainen, J Isaacs
Jan 1, 1986·The Prostate·M L MontpetitM Tenniswood
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K W WattR Loor
Apr 1, 1987·Annals of Neurology·D A Greenberg
Aug 1, 1989·Molecular and Cellular Biology·R ButtyanI S Sawczuk
Dec 1, 1987·Molecular Endocrinology·V E QuarmbyF S French
Aug 17, 1989·The New England Journal of Medicine·E D CrawfordP J Goodman
Nov 30, 1989·Biochemical and Biophysical Research Communications·N Kyprianou, J T Isaacs
Oct 23, 1989·FEBS Letters·J Palvimo, A Linnala-Kankkunen
Nov 17, 1988·Nature·J C ReedP C Nowell
Jun 21, 1985·Science·Y TsujimotoC M Croce
Mar 20, 1968·Archives of Biochemistry and Biophysics·D S CoffeyH G Williams-Ashman
Jan 1, 1984·The Prostate·J T Isaacs
Jan 1, 1980·International Review of Cytology·A H WyllieA R Currie
Mar 1, 1981·Proceedings of the Society for Experimental Biology and Medicine·A S GoldmanR Piddington
Aug 27, 1981·Biochimica Et Biophysica Acta·S R UmanskyP A Nelipovich
Jan 1, 1995·CA: a Cancer Journal for Clinicians·P A WingoS Bolden
Oct 20, 1993·Journal of the National Cancer Institute·N M NavoneC J Conti

❮ Previous
Next ❯

Citations

Apr 10, 2012·Bioscience, Biotechnology, and Biochemistry·Yuri KimJung-Hyun Kim
Feb 16, 2006·Molecular and Cellular Biology·Yuting LinJialing Xiang
Jul 26, 2007·BMC Urology·Kent L NastiukJohn J Krolewski
Dec 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yao DaiLiang Xu
Apr 29, 2009·Asian Journal of Andrology·Zai-Xian ZhangXiao-Feng Wang
Jul 6, 2010·Nature Genetics·Michael C HaffnerSrinivasan Yegnasubramanian
Apr 10, 2002·American Journal of Veterinary Research·Kaitkanoke SirinarumitrMargaret V Root Kustritz
Jun 29, 2001·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·S A BeresfordN J Donato
Dec 10, 1999·The New England Journal of Medicine·M A Eisenberger, P C Walsh
Jan 9, 2010·Expert Opinion on Therapeutic Targets·Kerrilyn R DienerJohn D Hayball
Nov 5, 2014·Expert Opinion on Drug Discovery·Richard C LauerWadih Arap
Jan 5, 2002·Expert Opinion on Investigational Drugs·M C Filion, N C Phillips
Jul 5, 2005·Expert Opinion on Investigational Drugs·S C Dixon, I N Arah
Jun 19, 2001·Cancer Investigation·E M RosenI D Goldberg
Dec 15, 2012·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Keyuna S CameronPaul B Tchounwou
Oct 23, 2012·Clinical Genitourinary Cancer·Connor HallMin H Kang
Mar 5, 2011·Biochemical and Biophysical Research Communications·Su-Hwa KimJu-Hong Jeon
Dec 22, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chunlong LiBao Li
May 16, 2009·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Brian Y Y WongJianping Zheng
Sep 29, 2004·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·R RibeiroR Medeiros
Dec 24, 2005·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Sung-Dae ChoKyung-Sun Kang
Dec 1, 2008·Surgical Pathology Clinics·S Joseph Sirintrapun, Anil V Parwani
Mar 18, 2009·Bioorganic & Medicinal Chemistry Letters·Jie LiuRyuichiro Kondo
May 13, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·James L Mohler
Feb 16, 2008·Toxicology and Applied Pharmacology·Syed M MeeranSantosh K Katiyar
Sep 18, 2007·Phytochemistry·Jana MalíkováMiroslav Strnad
Sep 10, 2014·Computers in Biology and Medicine·Pegah KhosraviBahram Goliaei
Feb 16, 2005·Proteomics·Hidetoshi KurumaShiro Baba
Sep 25, 2004·The Prostate·Hiroshi MiyamotoChawnshang Chang
Sep 25, 2004·The Prostate·Katrine Frønsdal, Fahri Saatcioglu
Jun 18, 2003·Journal of Cellular Physiology·Kent L NastiukJohn J Krolewski
Dec 23, 2003·Journal of Cellular Biochemistry·Natalya V GusevaMichael B Cohen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis